A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Tumours · Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small-Cell Lung · Colorectal Neoplasms · Triple Negative Breast Neoplasms · Carcinoma, Renal Cell (Clear Cell Only) · Esophageal Neoplasms · Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors) · Uterine Cervical Neoplasms · Ovarian Neoplasms · Pancreatic Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Guy's Hopsital, London, United Kingdom
Contact: Study coordinator (James Spicer, Dr) · James.Spicer@kcl.ac.uk · +44 (0)20 7188 4260
The Christie NHS Foundation Trust, Manchester, United Kingdom
Contact: Study coordinator (Fiona Thistlethwaite, Prof) · the-christie.ecmt.enquiries@nhs.net · +44 (0)161 9187672
The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Contact: Study coordinator (Christoph Oing, Dr) · c.oing@nhs.net · +44 (0)191 213 8476
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
Contact: Study coordinator (Ioannis Karydis, Prof) · I.Karydis@soton.ac.uk

Study leads

Fiona Thistlethwaite, Prof
Principal Investigator
The Christie NHS Foundation Trust

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

Neoplasms

IsraelRecruitingPHASE1

Stanford, United States · Denver, United States